NasdaqCM - Delayed Quote USD
Intelligent Bio Solutions Inc. (INBS)
At close: November 4 at 4:00 PM EST
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-9,571.5690
-9,571.5690
-7,377.3780
-3,358.0340
-11,296.4770
Investing Cash Flow
-221.4260
-221.4260
-694.1420
-880.2210
--
Financing Cash Flow
14,560.5560
14,560.5560
1,435.3230
--
23,402.9180
End Cash Position
6,304.0980
6,304.0980
1,537.2440
8,238.3010
12,573.6850
Interest Paid Supplemental Data
--
--
--
--
185.3010
Capital Expenditure
-221.4260
-221.4260
-505.1230
-380.2210
--
Issuance of Capital Stock
12,903.7450
12,903.7450
2,775.0410
--
24,894.7580
Free Cash Flow
-9,792.9950
-9,792.9950
-7,882.5010
-3,738.2550
-11,296.4770
6/30/2021 - 12/23/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HSCS HeartSciences Inc.
2.7300
-6.83%
BBLG Bone Biologics Corporation
1.2900
-0.77%
AIMD Ainos, Inc.
0.4400
-3.30%
VTAK Catheter Precision, Inc.
0.5100
+0.39%
SINT Sintx Technologies, Inc.
2.9300
-4.56%
TNON Tenon Medical, Inc.
3.4300
-8.53%
OPGN OpGen, Inc.
1.7500
-0.57%
TBIO Telesis Bio, Inc.
1.4500
+7.41%
RSLS ReShape Lifesciences Inc.
6.05
+2.89%
AEMD Aethlon Medical, Inc.
0.3990
+4.61%